eslicarbazepine acetate has been researched along with Bipolar Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, L; Costa, R; Falcão, A; Grunze, H; Kotlik, E; Nunes, T; Soares-da-Silva, P | 1 |
| Almeida, L; Falcão, A; Gellert, M; Maia, J; Mazur, D; Soares-da-Silva, P | 1 |
2 trial(s) available for eslicarbazepine acetate and Bipolar Disorder
| Article | Year |
|---|---|
Assessment of the efficacy and safety of eslicarbazepine acetate in acute mania and prevention of recurrence: experience from multicentre, double-blind, randomised phase II clinical studies in patients with bipolar disorder I.
Topics: Acute Disease; Adult; Aged; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Dibenzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Recurrence; Secondary Prevention; Treatment Outcome | 2015 |
Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Bipolar Disorder; Dibenzazepines; Female; Humans; Male | 2005 |